Skip to main content

Company ESG Risk Ratings

Hubei Biocause Pharmaceutical Co., Ltd.

Industry Group: Pharmaceuticals

Country/Region: China

Identifier: SHE:000627

Full time employees: 1,765

ESG Risk Rating

Core
39.5
High Risk
0-10
10-20
20-30
30-40
40+

Ranking

Industry Group (1st = lowest risk)

Pharmaceuticals 878 out of 918


Universe

Global Universe 14780 out of 16073


Last Full Update: Dec 20, 2023
Last Update: Dec 20, 2023

What are the ESG Risk Ratings?

Compare Hubei Biocause Pharmaceutical Co., Ltd. with other industry peers.

Industry Comparison

Company ESG Risk Rating Industry Rank
Zhejiang Xianju Pharmaceutical Co., Ltd.
29.5
 
 
 
 
 
Medium
498 out of 918
Tibet Cheezheng Tibetan Medicine Co., Ltd.
31.5
 
 
 
 
 
High
599 out of 918
Tibet Rhodiola Pharmaceutical Holding Co.
33
 
 
 
 
 
High
663 out of 918
Neuren Pharmaceuticals Ltd.
34.1
 
 
 
 
 
High
719 out of 918
Hubei Biocause Pharmaceutical Co., Ltd.
39.5
 
 
 
 
 
High
878 out of 918

For corporate professionals interested in direct competitor insights

Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.

Our Approach to Calculating ESG Risk

The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.

Hubei Biocause Pharmaceutical Co., Ltd.'s Exposure is Medium

Low
Medium
High

Management

Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.

Hubei Biocause Pharmaceutical Co., Ltd.'s Management of ESG Material Risk is Average

Weak
Average
Strong

How do the ESG Risk Ratings work?

Learn how the ESG Risk Ratings are used by our clients

Corporates

Leverage Sustainalytics' ESG Risk Ratings to understand and promote your corporate ESG performance with internal and external stakeholders.

Banks and Lenders

Banks and lenders can use our ESG Risk Ratings and data as a part of a broader analysis of their clients as well as for innovative product solutions such as sustainability linked loans.

Investors

The ESG Risk Ratings can help investors to identify, understand and manage ESG risks at the security and portfolio level with the aim of improving the long-term performance of their equity and fixed income securities.